Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction

Summary

Phase : Phase III Indication : Erectile Dysfunction Study Design : open-label, fixed dose, 6-month extension study (parent study : DA8159\_EDD\_III)

Timeline

Start

2011-11

Primary completion

2012-11

Completion

2012-11

Drugs

Indications